Inhibition of DNA methylation in malignant MOLT F4 lymphoblasts by 6- mercaptopurine

9Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Treatment of MOLT F4 lymphoblasts with 6-mercaptopurine (6-MP) resulted in a decrease of ATP and a depletion of S-adenosylmethionine (AdoMet). To investigate whether this might affect the methylation of DNA, we treated MOLT F4 lymphoblasts with increasing concentrations of 6-MP, followed by labeling with [methyl-14C]methionine and [methyl-3H]thymidine. After DNA isolation, we measured the incorporated radioactivity and determined the 14C/3H ratio as a measure for the methylation of newly formed DNA. The 14C/3H ratio was decreased by 17% with 1 μmol/L 6-MP; treatment with increasing concentrations of 6-MP up to 10 μmol/L showed a further decrease to 70%, in comparison with untreated cells. To demonstrate that the methylation of deoxycytidine residues in DNA was reduced, we quantified hydrolyzed DNA by HPLC. The 14C/3H ratio showed a decrease with increasing 6-MP concentrations, indicating that treatment with 6-MP resulted in hypomethylation of DNA.

Cite

CITATION STYLE

APA

Lambooy, L. H. J., Leegwater, P. A. J., Van Den Heuvel, L. P., Bökkerink, J. P., & De Abreu, R. A. (1998). Inhibition of DNA methylation in malignant MOLT F4 lymphoblasts by 6- mercaptopurine. Clinical Chemistry, 44(3), 556–559. https://doi.org/10.1093/clinchem/44.3.556

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free